Answer
Strong CYP3A inhibitors are contraindicated with venetoclax at treatment initiation and during the dose-titration phase in patients with chronic lymphocytic leukaemia.
Sources for this answer
- Venclyxto 10mg film-coated tabletsAbbVie Ltd · emc · SmPC §4.3 Contraindications · Version 26Document updated
Sources checked